OM
Opaleye Management Inc. bought $33K of GRCE stock
Opaleye Management Inc., 10% owner of Grace Therapeutics, Inc. (GRCE), bought 18,442 shares of GRCE stock worth $33K, per an SEC Form 4 filed Nov 6, 2026.
It was an open-market purchase.
The trade happened on Nov 3, 2026, 3 days before it was made public.
GRCE has moved +0.5% since the trade date, from $1.84 to $1.85 (Nov 6, 2026 close).
- Traded
- Nov 3, 2026
- Disclosed
- Nov 6, 2026
- Filing delay
- 3 days
- Price since
- +0.5%
- Role
- 10% owner
- Source
- SEC Form 4